Accendra Health Inc Liquidation Value

ACH Other

Cash & Equivalents

$281.99M
As of 2025-12-31
Current Price: $3.36 (as of 2026-04-24)

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $281.99M
Total Obligations: -$2.86B
$-2.58B
Per share: $-33.76
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $281.99M
AR: $0
Total Obligations: -$2.86B
$-2.58B
Per share: $-33.76
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $281.99M
AR: $0
Inventory: $74.44M
Total Obligations: -$2.86B
$-2.50B
Per share: $-32.78
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-2.58B$-33.76
Liquid Liquidation Value$-2.58B$-33.76
Operating Liquidation Value$-2.50B$-32.78

Key Components (as of 2025-12-31)

Cash & Equivalents$281.99M
Accounts ReceivableN/A
Inventory$74.44M
Current Liabilities$947.08M
Long-term Debt$1.80B
Op. Lease Liability$113.59M
Finance Lease$9.78M
Shares Outstanding76.4M

Explore all 212 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$281.99MN/A$74.44M$363.56M$947.08M$1.80B$113.59MN/A
2025-09-30$32.84MN/A$63.85M$339.73M$2.47B$1.84B$127.38MN/A
2025-06-30$38.26MN/A$69.23M$357.04M$2.67B$1.59B$124.69MN/A
2025-03-31$59.44MN/A$1.41B$1.38B$1.96B$1.90B$324.03MN/A
2024-12-31$27.57MN/A$67.58M$359.93M$1.85B$1.80B$130.68M$9.78M
2024-09-30$45.45MN/A$1.24B$1.34B$1.93B$1.84B$288.04MN/A
2024-06-30$243.67MN/A$1.23B$1.38B$2.13B$1.87B$297.73MN/A
2024-03-31$244.87MN/A$1.14B$1.22B$1.93B$1.95B$276.33MN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-02-20 View
2025-09-30 10-Q 2025-10-31 View
2025-06-30 10-Q 2025-08-11 View
2025-03-31 10-Q 2025-05-08 View
2024-12-31 10-K 2025-02-28 View
2024-09-30 10-Q 2024-11-04 View
2024-06-30 10-Q 2024-08-02 View
2024-03-31 10-Q 2024-05-03 View

Community Notes

Loading notes...

Questions

Loading questions...